Literature DB >> 21269131

Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa.

Krisda Chaiyachati1, Lisa R Hirschhorn, Frank Tanser, Marie-Louise Newell, Till Bärnighausen.   

Abstract

Simple questions are the most commonly used measures of antiretroviral treatment (ART) adherence in sub-Saharan Africa (SSA), but rarely validated. We administered five adherence questions in a public-sector primary care clinic in rural South Africa: 7-day recall of missed doses, 7-day recall of late doses, a six-level Likert item, a 30-day visual analogue scale of the proportion of doses missed, and recall of the time when an ART dose was last missed. We estimated question sensitivity and specificity in detecting immunologic (or virologic) failure assessed within 45 days of the adherence question date. Of 165 individuals, 7% had immunologic failure; 137 individuals had viral loads with 9% failure detected. The Likert item performed best for immunologic failure with sensitivity/specificity of 100%/5% (when defining nonadherence as self-reported adherence less than "excellent"), 42%/55% (less than "very good"), and 25%/95% (less than "good"). The remaining questions had sensitivities ≤17%, even when the least strict cutoffs defined nonadherence. When we stratified the analysis by gender, age, or education, question performance was not substantially better in any of the subsamples in comparison to the total sample. Five commonly used adherence questions performed poorly in identifying patients with treatment failure in a public-sector ART program in SSA. Valid adherence measurement instruments are urgently required to identify patients needing treatment support and those most at risk of treatment failure. Available estimates of ART adherence in SSA are mostly based on studies using adherence questions. It is thus unlikely that our understanding of ART adherence in the region is correct.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269131      PMCID: PMC3048836          DOI: 10.1089/apc.2010.0257

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  51 in total

1.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

2.  HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.

Authors:  Jonathan Shuter; Julie A Sarlo; Tina J Kanmaz; Richard A Rode; Barry S Zingman
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

3.  Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.

Authors:  Charles Kouanfack; Christian Laurent; Gilles Peytavin; Laura Ciaffi; Maguy Ngolle; Yvette Mawamba Nkene; Claudine Essomba; Alexandra Calmy; Eitel Mpoudi-Ngolé; Eric Delaporte; Sinata Koulla-Shiro
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

Review 4.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

Review 5.  Treatment Options for HIV-Associated Tuberculosis.

Authors:  Philip Chukwuka Onyebujoh; Isabela Ribeiro; Christopher Curtis Whalen
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

6.  Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience.

Authors:  F Mugusi; S Mugusi; M Bakari; B Hejdemann; R Josiah; M Janabi; S Aboud; E Aris; H Swai; F Mhalu; G Biberfeld; K Pallangyo; E Sandstrom
Journal:  Trop Med Int Health       Date:  2009-09-03       Impact factor: 2.622

7.  Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

Authors:  Jean-Jacques Parienti; Véronique Massari; Diane Descamps; Astrid Vabret; Elisabeth Bouvet; Bernard Larouzé; Renaud Verdon
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

8.  Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique.

Authors:  Cynthia R Pearson; Mark A Micek; Jane M Simoni; Peter D Hoff; Eduardo Matediana; Diane P Martin; Stephen S Gloyd
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

9.  Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

Authors:  Catherine Orrell; Guy Harling; Stephen D Lawn; Richard Kaplan; Matthew McNally; Linda-Gail Bekker; Robin Wood
Journal:  Antivir Ther       Date:  2007

10.  Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

Authors:  Jean-Jacques Parienti; Moupali Das-Douglas; Véronique Massari; David Guzman; Steven G Deeks; Renaud Verdon; David R Bangsberg
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  17 in total

Review 1.  Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies.

Authors:  Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

2.  A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy.

Authors:  Tamsin Phillips; Kirsty Brittain; Claude A Mellins; Allison Zerbe; Robert H Remien; Elaine J Abrams; Landon Myer; Ira B Wilson
Journal:  AIDS Behav       Date:  2017-02

Review 3.  Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.

Authors:  Till Bärnighausen; Krisda Chaiyachati; Natsayi Chimbindi; Ashleigh Peoples; Jessica Haberer; Marie-Louise Newell
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

4.  Short Communication: Early Antiretroviral Therapy Is Associated with Better Viral Suppression and Less HIV Drug Resistance After Implementation of Universal Treatment in South Africa.

Authors:  Jienchi Dorward; Paul K Drain; Farzana Osman; Yukteshwar Sookrajh; Melendhran Pillay; Pravikrishnen Moodley; Nigel Garrett
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-04       Impact factor: 2.205

5.  High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.

Authors:  Justen Manasa; Richard J Lessells; Andrew Skingsley; Kevindra K Naidu; Marie-Louise Newell; Nuala McGrath; Tulio de Oliveira
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 6.  Representation of women and pregnant women in HIV research: a limited systematic review.

Authors:  Daniel Westreich; Molly Rosenberg; Sheree Schwartz; Geeta Swamy
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

7.  Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.

Authors:  Collins C Iwuji; Joanna Orne-Gliemann; Frank Tanser; Sylvie Boyer; Richard J Lessells; France Lert; John Imrie; Till Bärnighausen; Claire Rekacewicz; Brigitte Bazin; Marie-Louise Newell; François Dabis
Journal:  Trials       Date:  2013-07-23       Impact factor: 2.279

8.  Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.

Authors:  Joanna Orne-Gliemann; Joseph Larmarange; Sylvie Boyer; Collins Iwuji; Nuala McGrath; Till Bärnighausen; Thembelile Zuma; Rosemary Dray-Spira; Bruno Spire; Tamsen Rochat; France Lert; John Imrie
Journal:  BMC Public Health       Date:  2015-03-01       Impact factor: 3.295

9.  Development of an electronic medical record based alert for risk of HIV treatment failure in a low-resource setting.

Authors:  Nancy Puttkammer; Steven Zeliadt; Jean Gabriel Balan; Janet Baseman; Rodney Destiné; Jean Wysler Domerçant; Garilus France; Nathaelf Hyppolite; Valérie Pelletier; Nernst Atwood Raphael; Kenneth Sherr; Krista Yuhas; Scott Barnhart
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

10.  Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.

Authors:  Rimke Bijker; Awachana Jiamsakul; Cissy Kityo; Sasisopin Kiertiburanakul; Margaret Siwale; Praphan Phanuphak; Sulaimon Akanmu; Romanee Chaiwarith; Ferdinand W Wit; Benedict Lh Sim; Tamara Sonia Boender; Rossana Ditangco; Tobias F Rinke De Wit; Annette H Sohn; Raph L Hamers
Journal:  J Int AIDS Soc       Date:  2017-03-03       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.